Hepatitis, Drug-Induced
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
418
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Chemically-Induced Liver Toxicity
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
413
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
193
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Aortic Aneurysm, Abdominal
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
586
|
90
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Squamous cell carcinoma of oropharynx
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
155
|
33
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Leiomyosarcoma of uterus
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
71
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Superficial spreading malignant melanoma of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
25
|
2
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Stage I Cutaneous Melanoma AJCC v6
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Dermatofibrosis lenticularis disseminata
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
11
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Follicular adenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
183
|
5
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Carcinoma, Endometrioid
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
223
|
12
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
877
|
43
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Congenital contractural arachnodactyly
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Congenital Abnormality
|
559
|
48
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Anaplastic thyroid carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
392
|
16
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Systemic Inflammatory Response Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
185
|
9
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Sepsis
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
1453
|
144
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adenocarcinoma of colon
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
406
|
10
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Intrahepatic Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
470
|
19
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |